Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 28, 2014; 20(48): 18413-18419
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18413
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18413
Table 1 Clinical data of the 53 patients
| Item | Data |
| Gender | |
| Male | 37 |
| Female | 16 |
| Age (yr, mean ± SD) | 60.30 ± 9.41 |
| Karnofsky score | |
| 90 | 7 |
| 80 | 20 |
| 70 | 22 |
| 60 | 4 |
| Tumor stage | |
| III | 24 |
| IV | 29 |
| Pathological type | |
| Poorly differentiated adenocarcinoma | 23 |
| Undifferentiated adenocarcinoma | 12 |
| Signet-ring cell carcinoma | 18 |
| Tumor location | |
| Gastric fundus and cardia | 11 |
| Gastric corpus | 14 |
| Gastric antrum and pylorus | 25 |
| Sclerotic stomach | 3 |
| Tumor size (cm), mean ± SD | 5.6 ± 1.5 |
| Chemotherapeutic course | |
| 1 course | 2 |
| 2 courses | 20 |
| 3 courses | 16 |
| 4 courses | 15 |
- Citation: Yu YJ, Sun WJ, Lu MD, Wang FH, Qi DS, Zhang Y, Li PH, Huang H, You T, Zheng ZQ. Efficacy of docetaxel combined with oxaliplatin and fluorouracil against stage III/IV gastric cancer. World J Gastroenterol 2014; 20(48): 18413-18419
- URL: https://www.wjgnet.com/1007-9327/full/v20/i48/18413.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i48.18413